The incretin effect is greatly affected in patients with type 2 diabetes, with the insulinotropic influence of the GIP hormone being diminished in pancreatic beta cells and the effect of GLP-1 reduced. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.